Skip to content

The clinical and basic research of Jiawei Buzhong Yiqi Decoction Directed Administration for the treatment of stress urinary incontinence

The clinical and basic research of Jiawei Buzhong Yiqi Decoction Directed Administration for the treatment of stress urinary incontinence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000640
Enrollment
Unknown
Registered
2025-04-02
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

woman stress urinary incontinence

Interventions

Intervention group:Jiawei Buzhong Yiqi Decoction Directed Administration
Control group:Kegel exercise

Sponsors

Women's Hospital School of Medicine Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) The diagnosis of western medicine is in line with the diagnostic criteria of the Diagnosis and Treatment Guide for Female Stress Urinary Incontinence (2017) of the Pelvic Floor Group of the Gynecology and Gynecology Branch of the Chinese Medical Association; The diagnosis of TCM is in line with the diagnostic criteria of spleen-kidney deficiency syndrome in Guiding Principles for Clinical Research of New Chinese Medicine. 2) 40-70 years old women with a sexual life history subjects with uterine menopause =1 year subjects without uterus =55 years old; 3) Patients voluntarily accept clinical observation and sign informed consent; 4) The patient has not seen a doctor for PFD or has had to stop PFD-related medication or physical therapy for more than 3 months.

Exclusion criteria

Exclusion criteria: 1) Other types of urinary incontinence that do not meet the inclusion criteria; 2) Patients with severe medical and surgical diseases; 3) The treatment site is damaged ulcerated or infected; 4) Acute infection high fever coma; 5) heart liver and renal insufficiency; 6) Patients with history of lower extremity deep vein thrombosis or malignant tumor; 7) Patients with consciousness and communication disorders could not cooperate with the experiment; 8) Patients who are deemed unsuitable by medical staff for other reasons.

Design outcomes

Primary

MeasureTime frame
Gynecologic urinary ultrasound;PISQ-12;IIQ-7;ICI-Q-SF;

Secondary

MeasureTime frame
72-hour urination diary;Urine flow rate;urine pad test;

Countries

China

Contacts

Public ContactZhenwei Xie

Women's Hospital School of Medicine Zhejiang University

xiezw@zju.edu.cn13588030456

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026